Spironolactone Use and Higher Hospital Readmission for Medicare Beneficiaries with Heart Failure, Left Ventricular Ejection Fraction <45% and Estimated Glomerular Filtration Rate <45 ml/min/1.73m(2)

While randomized controlled trials have demonstrated benefits of aldosterone antagonists for patients with heart failure and reduced ejection fraction (HFrEF), they excluded patients with serum creatinine >2.5mg/dl and their use is contraindicated in those with advanced chronic kidney disease (CK...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Inampudi, Chakradhari, Parvataneni, Sridivya, Morgan, Charity J., Deedwania, Prakash, Fonarow, Gregg C., Sanders, Paul W., Prabhu, Sumanth D., Butler, Javed, Forman, Daniel E., Aronow, Wilbert S., Allman, Richard M., Ahmed, Ali
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2014
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4169696/
https://ncbi.nlm.nih.gov/pubmed/24846806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2014.03.062
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge